Bayer, Janssen Pay $775M To End Xarelto Suits

By Emily Field · March 25, 2019, 10:53 AM EDT

Bayer and Janssen Pharmaceuticals announced a $775 million deal Monday to settle about 25,000 lawsuits alleging that the companies failed to warn about internal bleeding risks caused by blood thinner Xarelto....

To view the full article, register now.

Case Information

Case Title

In Re: Xarelto (Rivaroxaban) Products Liability Litigation

Case Number

2:14-md-02592

Court

Louisiana Eastern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

December 12, 2014